Cargando…

Serum Markers of Intrahepatic Cholangiocarcinoma

Cholangiocarcinoma (CCA) is a relatively rare type of primary liver cancer that originates in the bile duct epithelium. It is an aggressive malignancy typified by unresponsiveness to chemotherapy and radiotherapy. Despite advances in radiologic techniques and laboratory diagnostic test, the diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Malaguarnera, Giulia, Paladina, Isabella, Giordano, Maria, Malaguarnera, Michele, Bertino, Gaetano, Berretta, Massimiliano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3809974/ https://www.ncbi.nlm.nih.gov/pubmed/23396291 http://dx.doi.org/10.3233/DMA-130964

Ejemplares similares

Elevated serum levels of Chromogranin A in hepatocellular carcinoma
por: Biondi, Antonio, et al.
Publicado: (2012)

Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
por: Bertino, Gaetano, et al.
Publicado: (2014)

The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: Bertino, Gaetano, et al.
Publicado: (2015)

Carnitine Serum Levels in Frail Older Subjects
por: Malaguarnera, Giulia, et al.
Publicado: (2020)

Serum Folate deficiency in HCV related Hepatocellular Carcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2022)

High Carbohydrate 19-9 Antigen Serum Levels in Patients with Nonmelanoma Skin Cancer and Primary Occult Cancer
por: Malaguarnera, Giulia, et al.
Publicado: (2020)

D-dimer plasmatic levels as a marker for diagnosis and prognosis of hepatocellular carcinoma patients with portal vein thrombosis
por: Malaguarnera, Michele, et al.
Publicado: (2018)

Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
por: Bertino, Gaetano, et al.
Publicado: (2018)

Carcinoembryonic Antigen Serum Levels in Nonmelanoma Skin Cancer
por: Latteri, Saverio, et al.
Publicado: (2018)

Anorectal mucosal melanoma
por: Malaguarnera, Giulia, et al.
Publicado: (2018)

Folate levels in hepatocellular carcinoma patients with portal vein thrombosis
por: Malaguarnera, Giulia, et al.
Publicado: (2020)

Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications
por: Berretta, Massimiliano, et al.
Publicado: (2016)

Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial
por: Malaguarnera, Giulia, et al.
Publicado: (2014)

Resveratrol in Patients with Minimal Hepatic Encephalopathy
por: Malaguarnera, Giulia, et al.
Publicado: (2018)

Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance
por: Pennisi, Manuela, et al.
Publicado: (2017)

Rare Benign Tumors of the Liver: Still Rare?
por: Bertino, Gaetano, et al.
Publicado: (2014)

Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients
por: Malaguarnera, Michele, et al.
Publicado: (2011)

Potential role of probiotics on colorectal cancer prevention
por: Uccello, Mario, et al.
Publicado: (2012)

Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability
por: Malaguarnera, Giulia, et al.
Publicado: (2016)

Carbohydrate 19.9 Antigen Serum Levels in Liver Disease
por: Bertino, Gaetano, et al.
Publicado: (2013)

Vitamin D Serum Levels in Patients with Statin-Induced Musculoskeletal Pain
por: Pennisi, Manuela, et al.
Publicado: (2019)

Prediction of Multiple Serum Tumor Markers in Hepatolithiasis Complicated with Intrahepatic Cholangiocarcinoma
por: Zhao, Hua, et al.
Publicado: (2022)

Lipoprotein(a) in Cardiovascular Diseases
por: Malaguarnera, Michele, et al.
Publicado: (2013)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

Decrease in Serum Vitamin D Level of Older Patients with Fatigue
por: Pennisi, Manuela, et al.
Publicado: (2019)

Lipoprotein(a) Serum Levels in Diabetic Patients with Retinopathy
por: Malaguarnera, Giulia, et al.
Publicado: (2013)

Effects of l-Carnitine in Patients with Autism Spectrum Disorders: Review of Clinical Studies
por: Malaguarnera, Michele, et al.
Publicado: (2019)

Tumor lysis syndrome in an extraskeletal osteosarcoma: a case report and review of the literature
por: Catania, Vito Emanuele, et al.
Publicado: (2017)

Intrahepatic cholangiocarcinoma: current perspectives
por: Buettner, Stefan, et al.
Publicado: (2017)

Surgical Aspects of Intrahepatic Cholangiocarcinoma
por: Kupietzky, Amram, et al.
Publicado: (2022)

Locoregional Therapy for Intrahepatic Cholangiocarcinoma
por: Owen, Mackenzie, et al.
Publicado: (2023)

Risk of Hepatocellular Carcinoma in Workers Exposed to Chemicals
por: Uccello, Mario, et al.
Publicado: (2012)

Carnitine derivatives beyond fatigue: an update
por: Malaguarnera, Michele, et al.
Publicado: (2023)

The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
por: Fiste, Oraianthi, et al.
Publicado: (2021)

Preoperative Serum Markers and Risk Classification in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Study
por: Kaibori, Masaki, et al.
Publicado: (2022)

The role of microRNAs in intrahepatic cholangiocarcinoma
por: Li, Zheng, et al.
Publicado: (2016)

Systemic and Adjuvant Therapies for Intrahepatic Cholangiocarcinoma
por: Chun, Yun Shin, et al.
Publicado: (2017)

Epidemiology of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
por: Massarweh, Nader N., et al.
Publicado: (2017)

Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma
por: Akateh, Clifford, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i5foae36vm3pomvjo43rr50c4n